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Figure 1 Structure of the Markov model
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Figure 2: Scatterplot of the incremental cost-effectiveness of nasoduodenal FMT compared with 
vancomycin
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Figure 3: Scatterplot of the incremental cost-effectiveness of colorectal FMT compared with vancomycin
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